UK markets closed
  • FTSE 100

    7,901.80
    +81.64 (+1.04%)
     
  • FTSE 250

    20,593.46
    -21.23 (-0.10%)
     
  • AIM

    889.79
    +1.03 (+0.12%)
     
  • GBP/EUR

    1.1163
    -0.0042 (-0.37%)
     
  • GBP/USD

    1.2056
    -0.0173 (-1.41%)
     
  • BTC-GBP

    19,502.37
    -125.67 (-0.64%)
     
  • CMC Crypto 200

    535.42
    -1.43 (-0.27%)
     
  • S&P 500

    4,136.48
    -43.28 (-1.04%)
     
  • DOW

    33,926.01
    -127.93 (-0.38%)
     
  • CRUDE OIL

    73.23
    -2.65 (-3.49%)
     
  • GOLD FUTURES

    1,877.70
    -53.10 (-2.75%)
     
  • NIKKEI 225

    27,509.46
    +107.41 (+0.39%)
     
  • HANG SENG

    21,660.47
    -297.89 (-1.36%)
     
  • DAX

    15,476.43
    -32.76 (-0.21%)
     
  • CAC 40

    7,233.94
    +67.67 (+0.94%)
     

Americas Leading Cannabis and CBD brand Launches in Europe.

EQS-News: Ambari Brands Inc. / Key word(s): Miscellaneous
Americas Leading Cannabis and CBD brand Launches in Europe.
09.01.2023 / 08:30 CET/CEST
The issuer is solely responsible for the content of this announcement.

 

Americas Leading Cannabis and CBD brand Launches in Europe.

 

 

Ambari Brands is pleased to announce it has further expanded its European distribution from selling its products on line in almost every country in Europe to now being carried in Europe’s largest retailer, El Corte Ingles. Ambari Brands will continue its expansion into Germany, France, Portugal and Nordic Countries to begin.


Ambari Brands plans to focus on Germany for retailer brick and mortar retail locations in anticipation of cannabis legalization in 2023.

 

Ambari Brands is currently one of Americas leading CBD and Cannabis product manufacturer. Ambari is currently carried in Americas largest retailer such as Saks Fifth Avenue, Neiman Marcus, Bergdorf Goodman and many more.

 

Ambari Brands is backed by K. Kardashian, one of the world’s largest celebrities.

 

Ambari has been featured in almost every major publication in America and is growing consistently. It currently manufactures CBD skin care products and intends to expand its product offerings into vapes, gummies, capsules, indoor cannabis grow facilities and hemp outdoor production for CBD extraction.

 

With Germany plans to legalize Cannabis, Ambari brands is perfectly positioned to be one Europe’s leading cannabis and CBD manufacturers.  Once Germany legalizes Cannabis, many other European countries will follow Germany’s path to legalization and Ambari Brands will perfectly positioned with retail and online penetration all over Europe.

 

Ambari Brands shares are available for purchase In Germany under (WKN A3DP2A and ISIN CA2316X1024). The shares are also listed in Canada under symbol AMB and in the USA under symbol AMBBF. The company shares are publicly traded and have attracted much attention since its IPO.

 

With Europe’s energy crisis, Ambari Brands is the first cannabis company that is aiming to manufacture its products in manufacturing facilities powered by clean energy. Its initial goal is to produce in industrial hubs that are powered by wind and solar. Ambari’s final goal is to produce its European products in Hamburg’s green hydrogen hub which is set to be built in the next few years.


 

To Read a full report on Ambari, please visit

 

CBD im Kommen: Deutschlands "Grüner Goldrausch" - 14.11.2022 (wallstreet-online.de)

 

 

 

PR inquiries

 

inquiries@ambaribrands.com

Suite #300
9465 Wilshire Blvd. Beverly Hills, CA, 90210
United States

www.ambaribrands.com

 

 


09.01.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

show this
show this